Superior efficacy of letrozole versus tamoxifen as first-line therapy

被引：9

作者：

Buzdar, AU ^{[1
]}

机构：

[1] Univ Texas, MD Anderson Canc Ctr, Houston, TX 77030 USA

来源：

JOURNAL OF CLINICAL ONCOLOGY | 2002年 / 20卷 / 03期

关键词：

D O I：

10.1200/JCO.2002.20.3.876

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：876 / 877

页数：2

共 13 条

[1] Anastrozole versus tamoxifen as first-line therapy for advanced breast cancer in 668 postmenopausal women:: Results of the tamoxifen or arimidex randomized group efficacy and tolerability study [J].

Bonneterre, J ;

Thürlimann, B ;

Robertson, JFR ;

Krzakowski, M ;

Mauriac, L ;

Koralewski, P ;

Vergote, I ;

Webster, A ;

Steinberg, M ;

von Euler, M .

JOURNAL OF CLINICAL ONCOLOGY, 2000, 18 (22) :3748-3757

[2]

Bonneterre J, 2001, CANCER, V92, P2247, DOI 10.1002/1097-0142(20011101)92:9<2247::AID-CNCR1570>3.0.CO

[3]

2-Y

[4] Phase III, multicenter, double-blind, randomized study of letrozole, an aromatase inhibitor, for advanced breast cancer versus megestrol acetate [J].

Buzdar, A ;

Douma, J ;

Davidson, N ;

Elledge, R ;

Morgan, M ;

Smith, R ;

Porter, L ;

Nabholtz, J ;

Xiang, X ;

Brady, C .

JOURNAL OF CLINICAL ONCOLOGY, 2001, 19 (14) :3357-3366

[5] Letrozole, a new oral aromatase inhibitor for advanced breast cancer: Double-blind randomized trial showing a dose effect and improved efficacy and tolerability compared with megestrol acetate [J].

Dombernowsky, P ;

Smith, I ;

Falkson, G ;

Leonard, R ;

Panasci, L ;

Bellmunt, J ;

Bezwoda, W ;

Gardin, G ;

Gudgeon, A ;

Morgan, M ;

Fornasiero, A ;

Hoffmann, W ;

Michel, J ;

Hatschek, T ;

Tjabbes, T ;

Chaudri, HA ;

Hornberger, U ;

Trunet, PF .

JOURNAL OF CLINICAL ONCOLOGY, 1998, 16 (02) :453-461

[6]

GALE KE, 1994, CANCER, V73, P354, DOI 10.1002/1097-0142(19940115)73:2<354::AID-CNCR2820730220>3.0.CO

[7]

2-J

[8] RANDOMIZED CLINICAL-TRIAL OF TAMOXIFEN ALONE OR COMBINED WITH FLUOXYMESTERONE IN POSTMENOPAUSAL WOMEN WITH METASTATIC BREAST-CANCER [J].

INGLE, JN ;

TWITO, DI ;

SCHAID, DJ ;

CULLINAN, SA ;

KROOK, JE ;

MAILLIARD, JA ;

MARSCHKE, RF ;

LONG, HJ ;

GERSTNER, JG ;

WINDSCHITL, HE ;

EVERSON, LK ;

PFEIFLE, DM .

JOURNAL OF CLINICAL ONCOLOGY, 1988, 6 (05) :825-831

[9] Superior efficacy of letrozole versus tamoxifen as first-line therapy for postmenopausal women with advanced breast cancer:: Results of a phase III study of the international letrozole breast cancer group [J].

Mouridsen, H ;

Gershanovich, M ;

Sun, Y ;

Pérez-Carrión, R ;

Boni, C ;

Monnier, A ;

Apffelstaedt, J ;

Smith, R ;

Sleeboom, HP ;

Jänicke, F ;

Pluzanska, A ;

Dank, M ;

Becquart, D ;

Bapsy, PP ;

Salminen, E ;

Snyder, R ;

Lassus, M ;

Verbeek, JA ;

Staffler, B ;

Chaudri-Ross, HA ;

Dugan, M .

JOURNAL OF CLINICAL ONCOLOGY, 2001, 19 (10) :2596-2606

[10]

Mouridsen H., 2000, European Journal of Cancer, V36, pS88

← 1 2 →